The “Pediatric Interventional Cardiology Market by Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, APAC, and the Rest of the World.
Browse more than 90 market data tables with 19 figures spread through 165 pages and in-depth TOC on "Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018"
Early buyers will receive 10% customization on reports.
This report studies the global pediatric interventional cardiology market over the forecast period of 2013 to 2018. This market is valued at an estimated $894.7 million in 2013 and is poised to grow at a CAGR of 9.0% from 2013 to 2018.
Various new procedures and interventional devices are being developed and launched in the market, which is a major reason for the rapid growth of this market. Companies are heavily investing in R&D, to develop new and advanced devices that cater to the unmet needs of pediatric patients. Furthermore, the high growth potential of the transcatheter heart valves market is another factor that is propelling the growth of this market. Based on device type, the ASD, VSD, and PFO devices market accounted for the largest share of 28% in 2013. However, the transcatheter pulmonary valve market is poised to grow at the highest CAGR from 2013 to 2018.
Based on geography, the global pediatric interventional cardiology market is segmented into North America, Europe, APAC, and the Rest of the World (RoW). Europe accounts for the largest share of the pediatric interventional cardiology market; the large share of this region is attributed to factors such as the large number of approved interventional cardiology devices present in the European market, investments by venture capitalists, and collaborations among key players in the market.
The major players in the pediatric interventional cardiology market are St. Jude Medical, Inc. (U.S.), Medtronic, Inc. (U.S.), W.L. Gore & Associates, Inc. (U.S.), Edwards Lifesciences Corp (U.S.), NuMED, Inc. (U.S.), Cordis Corporation (U.S.), GE Healthcare (U.K), Siemens Healthcare (Germany), Boston Scientific (U.S.), and Abbott Vascular (U.S.), among others.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Email: [email protected]